Skip to main content

Advertisement

Log in

99mTc-MIBI uptake in metastatic renal cell carcinoma

  • Letters to the editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Derebek E, Kirkali Z, Dogan AS, Degirmenci B, Yilmaz M, Igci E, Yorukoglu K, Kovanlikaya I, Durak H.99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between99mTc-MIBI uptake and Pglycoprotein expression in tumour tissue.Eur J Nucl Med 1996; 23: 976–979.

    Google Scholar 

  2. Diggles L, Mena I, Khalkhali I. Technical aspects of prone dependent-breast scintimammography.J Nucl Med Technol 1994; 22: 165–170.

    Google Scholar 

  3. Moretti J-L, Azaloux H, Boisseron D, Kouyoumdjian J-C, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glyocprotein overexpression.Eur J Nucl Med 1996; 23: 980–986.

    Google Scholar 

  4. Mankoff DA, Gralow JR, Dunnwald LK, Druker MJ, Ellis G, Livingstone RB. [Tc-99m]-sestaMIBI scintimammography to measure response to neo-adjuvant chemotherapy.J Nucl Med 1996; 37: 252P.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Croasdale, I.R., Buscombe, J.R. & Hilson, A.J.W. 99mTc-MIBI uptake in metastatic renal cell carcinoma. Eur J Nucl Med 24, 88 (1997). https://doi.org/10.1007/BF01728317

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01728317

Keywords

Navigation